Document is current
Any future updates will be listed below
-
Authors
Zhang, Jialu
Fu, Yulong
Liu, Guanxing
Zhang, Yi
Zhang, Xuanxuan
Gao, Junying
Gao, Fan
Wu, Xing
Wang, Qian
Liu, Mingchen
Li, Kelei
Fu, Zhihao
Ma, Xiao
Xu, Miao
Liang, Zhenglun
Mao, Qunying
He, Qian
-
Funding
Funding for this research was provided by:
the State Key Laboratory of Drug Regulatory Science (2024SKLDRS0205)
- License Information
-
More Information
Article History
Received: 11 November 2025
Accepted: 1 May 2026
First Online: 11 May 2026
Declarations
:
: All animal immunization procedures were approved by the Institutional Animal Care and Use Committee of the National Institutes for Food and Drug Control, China (Approval No. 2022-B016). Viral challenge protocols were approved by the Animal Laboratory Center of Wuhan Institute of Biological Products Co., Ltd. (Ethical Approval No. WIBP-AII442021005). All animal experiments performed according to the guidelines for the ethical review of laboratory animal welfare People’s Republic of China National Standard GB/T 35892 − 2018.
: All authors have consented to the publication of this article.
: The authors declare no competing interests.
